Home Cart Sign in  
Chemical Structure| 78214-33-2 Chemical Structure| 78214-33-2

Structure of Ginsenoside Rh2
CAS No.: 78214-33-2

Chemical Structure| 78214-33-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ginsenoside Rh2 (Standard) is a reference standard for Ginsenoside Rh2, used for research and analytical applications. Ginsenoside Rh2 induces caspase-8 and caspase-9 activation and apoptosis in cancer cells through multiple pathways.

Synonyms: 20(S)-Ginsenoside Rh2; 20(S)-Rh2; AR1A4936

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ginsenoside Rh2

CAS No. :78214-33-2
Formula : C36H62O8
M.W : 622.87
SMILES Code : C[C@]([C@@](C[C@H]1O)([H])[C@]2(CC[C@@H]3O[C@]([C@@H]([C@@H](O)[C@@H]4O)O)([H])O[C@@H]4CO)C)(CC[C@@]2([H])C3(C)C)[C@]5([C@@]1([H])[C@]([C@@](C)(O)CC/C=C(C)/C)([H])CC5)C
Synonyms :
20(S)-Ginsenoside Rh2; 20(S)-Rh2; AR1A4936
MDL No. :MFCD00800712
InChI Key :CKUVNOCSBYYHIS-IRFFNABBSA-N
Pubchem ID :119307

Safety of Ginsenoside Rh2

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Ginsenoside Rh2

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
A549 10 μmol/L 24 hours To evaluate the anti-cancer effect of Ginsenoside Rh2 on A549 cells. Results showed that Eve-Rh2 significantly triggered cell death within 24 h with cell inhibitory rates of 55.44±4.73%. Acta Pharm Sin B. 2022 Mar;12(3):1240-1253
HCC827 10 μmol/L 24 hours To evaluate the anti-cancer effect of Ginsenoside Rh2 on HCC827 cells. Results showed that Eve-Rh2 significantly triggered cell death within 24 h with cell inhibitory rates of 54.80±12.83%. Acta Pharm Sin B. 2022 Mar;12(3):1240-1253
NCI-H1975 10 μmol/L 24 hours To evaluate the anti-cancer effect of Ginsenoside Rh2 on NCI-H1975 cells. Results showed that Eve-Rh2 significantly triggered cell death within 24 h with cell inhibitory rates of 78.24±8.74%. Acta Pharm Sin B. 2022 Mar;12(3):1240-1253
PC-3 cells 7.5 μg/mL 1-8 hours To investigate the apoptosis-inducing effect of G-Rh2 on p53-mutated PC-3 cells, results showed that G-Rh2 did not affect Fas expression and caspase-8 activity. Protein Cell. 2014 Mar;5(3):224-34
SW480 cells 7.5 μg/mL 1-8 hours To investigate the apoptosis-inducing effect of G-Rh2 on p53-mutated SW480 cells, results showed that G-Rh2 activated caspase-9 via the mitochondrial pathway but did not affect Fas expression and caspase-8 activity. Protein Cell. 2014 Mar;5(3):224-34
SK-HEP-1 cells 7.5 μg/mL 1-8 hours To investigate the apoptosis-inducing effect of G-Rh2 on SK-HEP-1 cells, results showed that G-Rh2 activated caspase-8 via p53-dependent Fas upregulation. Protein Cell. 2014 Mar;5(3):224-34
HeLa cells 7.5 μg/mL 1-8 hours To investigate the mechanism of G-Rh2-induced apoptosis, results showed that G-Rh2 significantly upregulated Fas and TNFR1 expression and activated caspase-8 via p53-dependent Fas upregulation. Protein Cell. 2014 Mar;5(3):224-34
MCF-7 cells 10 μM 72 hours Rh2 pretreatment mildly downregulated P-gp expression by reactivating the pentose phosphate pathway and rebalancing redox status, significantly increasing the growth inhibition effect and accumulation profile of adriamycin (ADR) throughout the multicellular tumor spheroid (MCTS) and improving drug penetration. Redox Biol. 2020 May;32:101452
SW480 cells 30-40 μM 48 hours To evaluate the cytotoxic effect of Rh2 on SW480 cells, results showed that Rh2 significantly induced cell death. Cancer Lett. 2011 Feb 28;301(2):185-92
HCT116 cells 35 μM 48 hours To evaluate the cytotoxic effect of Rh2 on HCT116 cells, results showed that Rh2 significantly induced cell death. Cancer Lett. 2011 Feb 28;301(2):185-92
MCA205 cells (mouse fibrosarcoma cells) 10 μM 16 hours To evaluate the effect of G-Rh2 on autophagy and ER stress, results showed that G-Rh2 enhanced autophagy and induced ER stress. Clin Transl Med. 2023 Feb;13(2):e1109
U2OS cells (human bone osteosarcoma epithelial cells) 1, 5, 10 μM 16 hours To evaluate the effect of G-Rh2 on autophagy marker LC3-II levels, results showed that G-Rh2 increased LC3-II levels. Clin Transl Med. 2023 Feb;13(2):e1109

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice MCF-7 subcutaneous tumor model Oral 50 mg/kg Once daily for 6 consecutive days Rh2 pretreatment and withdrawal downregulated P-gp expression by reactivating the pentose phosphate pathway and rebalancing redox status, significantly enhancing the penetration and antitumor effect of adriamycin in tumor tissues. Redox Biol. 2020 May;32:101452
BALB/c nude mice Lung cancer xenograft model Intragastric administration 5 mg/kg/day Once daily for 28 days To evaluate the anti-cancer effect of Ginsenoside Rh2 in vivo on lung cancer xenograft models. Results showed that Eve-Rh2 significantly suppressed tumor growth, and Rh2 alleviated the hepatic fat accumulation caused by Eve. Acta Pharm Sin B. 2022 Mar;12(3):1240-1253
BALB/c mice 4T1 breast carcinoma xenograft model Intravenous injection 10 mg/kg Every other day for 21 days To evaluate the anti-tumor effect of PTX-Rh2-lipo, results showed that PTX-Rh2-lipo significantly suppressed tumor growth and remodeled the tumor microenvironment. Nanomicro Lett. 2020 Jun 16;12(1):129
BALB/C mice Endometriosis (EMS) model Intraperitoneal injection 15 mg/kg, 30 mg/kg, 45 mg/kg Injected on day 4 and day 10, samples collected on day 14 To evaluate the effect of PPD on ectopic lesions in a mouse EMS model, results showed that PPD significantly reduced the number and weight of ectopic lesions and downregulated ERα expression while upregulating PRα expression. Cell Death Dis. 2018 May 1;9(5):574
C57BL/6 mice Lung cancer xenograft model Intraperitoneal injection 10 and 20 mg/kg/day Continuously for 21 days Inhibited tumor growth and metastasis with no significant toxicity Cell Death Dis. 2020 Aug 14;11(8):621

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.61mL

0.32mL

0.16mL

8.03mL

1.61mL

0.80mL

16.05mL

3.21mL

1.61mL

References

 

Historical Records

Categories